Login / Signup

A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank.

Do Hyun KimAubrey JensenKelly JonesSridharan RaghavanLawrence S PhillipsAdriana HungYan V SunGang LiPeter ReavenHua ZhouJin J Zhou
Published in: JAMIA open (2023)
Our publicly available pipeline and platform enable streamlined curation of incidence events, identification of time-varying risk factors underlying disease progression, and the definition of a relevant cohort for time-to-event analyses. These important steps need to be considered simultaneously to study disease progression.
Keyphrases
  • risk factors
  • high throughput
  • cardiovascular disease
  • type diabetes
  • cross sectional
  • glycemic control
  • insulin resistance